openPR Logo
Press release

Common Warts Treatment Market is expected to reach US$ 109.98 million by 2032 | Top key players - Pfizer Inc., GlaxoSmithKline plc, Verrica Pharmaceuticals.

11-10-2025 10:52 AM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

Common Warts Treatment Market

Common Warts Treatment Market

Market Size and Growth:

The Global Common Warts Treatment Market Size reached US$ 82.88 million in 2024 and is expected to reach US$ 109.98 million by 2032, growing with a CAGR of 3.6% during the forecast period 2024-2032. The Market is growing due to increasing prevalence of skin infections, rising awareness of dermatological care, and advancements in effective treatment options.

Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/common-warts-treatment-market?sz

The Common Warts Treatment Market encompasses the development, production, and commercialization of therapies and products aimed at treating common warts caused by human papillomavirus (HPV). It includes topical solutions, cryotherapy, laser treatments, and immunotherapy, targeting both adults and children. The market focuses on efficacy, safety, and accessibility of treatments across hospitals, clinics, and dermatology centers worldwide.

Industry Recent Developments: United States

✅ October 2025: Verrica Pharmaceuticals plans to begin a global Phase 3 program for YCANTH, a treatment for common warts, with first patient dosing expected by the end of 2025.

✅ September 2025: Increased adoption of topical treatments like zinc oxide ointments and 5-fluorouracil (5-FU) under tape occlusion has gained traction among clinicians for managing cutaneous viral warts.

✅ August 2025: Topical retinoids hold a dominant market share in common warts treatment in the U.S., owing to their ability to modulate keratinocyte differentiation and accelerate wart resolution.

Industry Recent Developments: Japan

✅ October 2025: Japan approved reimbursement listings for five new medicines related to common warts treatment, enhancing patient access to innovative therapies.

✅ August 2025: The Japanese common warts treatment market is growing due to high consumer preference for minimally invasive, fast-acting treatments supported by technological advances and integration of warts care into preventive dermatology.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/common-warts-treatment-market?sz

Regulatory / FDA Approval & Clearance Events:

✅ A device for wart/plantar‐wart removal: The Skin Clinic NitroClear Wart Remover received FDA 510(k) clearance in March 2025 (intended for OTC treatment of common and plantar warts in adults & children ages 4+).

✅ No new prescription drug specifically approved by the Food and Drug Administration (FDA) in 2025 yet for common warts / verruca vulgaris indication (though pipeline efforts are ongoing).

✅ An adjacent vaccine: Gardasil 9 (for HPV) has an FDA approval letter dated March 25 2025, for its existing indications including prevention of genital warts caused by HPV 6/11. While this is not a treatment for "common warts" on hands/feet, it is relevant in the broader wart/HPV space.

Major Key Players:

Prestige Consumer Healthcare Inc.
STADA Arzneimittel AG
Bausch Health Companies Inc.
Pfizer Inc.
Verrica Pharmaceuticals
GlaxoSmithKline plc
Taro pharmaceutical Industries Ltd.
Orgenesis biotech company
Teva pharmaceutical industries Ltd.
Novan Inc.

Segments Covered in the Common Warts Treatment Market:

By Treatment Type: Drug Therapy, Cryotherapy, Laser Therapy, Surgical Removal, Immunotherapy.

By Age Group: Pediatric, Adult.

By Sales Channel: End User, Distribution Channel.

Regional Analysis for Common Warts Treatment Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=common-warts-treatment-market

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Common Warts Treatment market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Common Warts Treatment Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Common Warts Treatment market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Common Warts Treatment Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlimited Insights. One Subscription: https://www.datamintelligence.com/reports-subscription

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Common Warts Treatment market?

➠ Who are the global key manufacturers of the Common Warts Treatment Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Common Warts Treatment market opportunities and threats faced by the vendors in the global Common Warts Treatment Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Common Warts Treatment market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Common Warts Treatment Market is expected to reach US$ 109.98 million by 2032 | Top key players - Pfizer Inc., GlaxoSmithKline plc, Verrica Pharmaceuticals. here

News-ID: 4261419 • Views:

More Releases from DataM Intelligence 4Market Research

Mitral Valve Regurgitation Treatment Market Set to Surge with Innovative Therapies in 2025 | Top Companies - Abbott Laboratories, Medtronic, Neovasc Inc.
Mitral Valve Regurgitation Treatment Market Set to Surge with Innovative Therapi …
Market Overview: The Global Mitral Valve Regurgitation Treatment Market is expected to reach at a Significant CAGR during the forecast period 2024-2031. Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/mitral-valve-regurgitation-treatment-market?sz The Mitral Valve Regurgitation Treatment Market encompasses therapies, devices, and interventions aimed at managing mitral valve insufficiency, a condition where the heart's mitral valve fails to close properly, causing blood leakage. It includes surgical repair, valve replacement, and minimally invasive procedures, alongside medications for
C3 Glomerulopathy Treatment Market is expected to reach US$ 4.25 billion by 2034 | Major key players - F. Hoffmann-La Roche Ltd., Mylan N.V., Sanofi.
C3 Glomerulopathy Treatment Market is expected to reach US$ 4.25 billion by 2034 …
Market Size and Growth: The Global C3 Glomerulopathy Treatment Market reached US$ 2.21 billion in 2024 and is expected to reach US$ 4.25 billion by 2034, growing with a CAGR of 6.7% during the forecast period 2025-2034. The Market is growing due to increasing prevalence of kidney disorders and rising adoption of targeted therapies for rare renal diseases. Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/c3-glomerulopathy-treatment-market?sz The C3 Glomerulopathy Treatment Market refers to the
Endoscopic Cold Light Sources Market is expected to reach US$ 8.5 billion by 2032 | Top Companies - Stryker Corporation, Olympus Corporation, Smith & Nephew Plc.
Endoscopic Cold Light Sources Market is expected to reach US$ 8.5 billion by 203 …
Market Size and Growth: The Global Endoscopic Cold Light Sources Market reached US$ 6.1 billion in 2024 and is expected to reach US$ 8.5 billion by 2032, growing at a CAGR of 4.23% during the forecast period 2024-2032. The Market is growing due to the rising adoption of minimally invasive procedures and technological advancements in endoscopic lighting systems. Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/endoscopic-cold-light-sources-market?sz The Endoscopic Cold Light Sources Market encompasses the
Fatty Acid Oxidation Disorder Drugs Market is expected to reach US$ 13.99 billion by 2029 | Top Companies - Pfizer Inc., Action Labs, Lonza Group Ltd.
Fatty Acid Oxidation Disorder Drugs Market is expected to reach US$ 13.99 billio …
Market Size and Growth: The Global Fatty Acid Oxidation Disorder Drugs Market Size reached US$ 9.55 billion in 2024 and is expected to reach US$ 13.99 billion by 2029, growing with a CAGR of 8.1% during the forecast period 2024-2029. The Market is growing due to increasing prevalence of fatty acid oxidation disorders and rising demand for targeted therapies and advanced treatment options. Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/fatty-acid-oxidation-disorder-drugs-market?sz The Fatty Acid

All 5 Releases


More Releases for Treatment

Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any